Related Experiment Videos
Diabetic vascular disease: it's all the RAGE
Barry I Hudson1, Thoralf Wendt, Loredana G Bucciarelli
1Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. bh2021@columbia.edu
Antioxidants & Redox Signaling
|December 17, 2005
Summary
Long-term diabetes causes vascular disease due to advanced glycation end products (AGEs). Blocking the receptor for AGEs (RAGE) shows promise in preventing and treating this condition.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Molecular Biology
Background:
- Diabetes mellitus is a major risk factor for vascular complications.
- Advanced glycation end products (AGEs) accumulate in diabetes due to hyperglycemia.
- AGEs interact with the Receptor for AGEs (RAGE), triggering inflammatory and procoagulatory pathways.
Purpose of the Study:
- To investigate the role of the RAGE pathway in diabetic vascular disease.
- To evaluate RAGE blockade as a potential therapeutic strategy.
Main Methods:
- Utilized rodent models of diabetic macro- and microvascular disease.
- Assessed the effects of blocking the RAGE pathway.
Main Results:
- RAGE activation by AGEs promotes proinflammatory and procoagulatory gene expression.
- Blockade of RAGE effectively prevented the development of vascular disease in diabetic rodent models.
Conclusions:
- The AGE-RAGE axis is a critical mediator of diabetic vascular complications.
- Targeting RAGE represents a promising therapeutic approach for managing diabetic vascular disease.